A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

NCT ID: NCT03495102

Last Updated: 2020-06-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

1842 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-05

Study Completion Date

2019-10-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the efficacy and safety of investigational doses of once weekly dulaglutide when added to metformin in participants with type 2 diabetes with inadequate blood sugar control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dulaglutide 1.5 mg

Dulaglutide 1.5 mg administered subcutaneously (SC) once a week.

Group Type ACTIVE_COMPARATOR

Dulaglutide

Intervention Type DRUG

Administered SC

Dulaglutide 3 mg

Dulaglutide 3 mg administered SC once a week.

Group Type EXPERIMENTAL

Dulaglutide

Intervention Type DRUG

Administered SC

Dulaglutide 4.5 mg

Dulaglutide 4.5 mg administered SC once a week.

Group Type EXPERIMENTAL

Dulaglutide

Intervention Type DRUG

Administered SC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dulaglutide

Administered SC

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

LY2189265

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have type 2 diabetes mellitus (T2DM) for at least 6 months
* Have been treated with stable metformin dose for at least 3 months
* Have HbA1c ≥7.5% and ≤11.0% at study entry
* Have body mass index (BMI) ≥25 kilograms per meter squared (kg/m\^2)

Exclusion Criteria

* Have type 1 diabetes mellitus
* Have used any glucagon-like peptide-1 receptor agonist (GLP-1 RA) or insulin, not including prior short term insulin use (≤14 days)
* Have been taking any other medicine for diabetes (other than metformin) during the last 3 months
* Have used in the last 3 months (or plan to use) prescription weight loss medications
* Have disorders associated with slowed emptying of the stomach contents, or have had any stomach surgeries for the purpose of weight loss
* Current participation in or intent to begin during the study an organized diet and/or exercise weight reduction program (other than the lifestyle and dietary measures for diabetes)
* Have acute or chronic hepatitis, signs and symptoms of any other liver disease other than nonalcoholic fatty liver disease (NAFLD), or alanine transaminase (ALT) level \>2.5 times the upper limit of the reference range, as determined by the central laboratory at study entry; participants with NAFLD are eligible for participation in this trial
* Had chronic or acute pancreatitis any time prior to study entry
* Have had a heart attack or stroke in the past 2 months, or have heart failure that significantly limits their physical activity
* Estimated glomerular filtration rate (eGFR) \<30 milliliters/minute/1.73m\^2 (or lower than the country-specific threshold for discontinuing metformin therapy per local label), calculated by the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, as determined by the central laboratory at study entry and confirmed at lead-in
* Have a personal or family history of medullary thyroid carcinoma or personal history of multiple endocrine neoplasia syndrome type 2
* Have proliferative retinopathy or maculopathy requiring acute treatment according to the opinion of the investigator
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eli Lilly and Company

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)

Role: STUDY_DIRECTOR

Eli Lilly and Company

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Synexus- Chandler

Chandler, Arizona, United States

Site Status

Synexus/Central Arizona Medical Associates, PC

Mesa, Arizona, United States

Site Status

Central Phoenix Med Clinic LLC

Phoenix, Arizona, United States

Site Status

Arkansas Clinical Research

Little Rock, Arkansas, United States

Site Status

Anaheim Clinical Trials, LLC

Anaheim, California, United States

Site Status

Valley Research

Fresno, California, United States

Site Status

National Research Institute

Huntington Park, California, United States

Site Status

National Research Institute

Los Angeles, California, United States

Site Status

Catalina Research Institute, LLC

Montclair, California, United States

Site Status

Valley Clinical Trials, Inc.

Northridge, California, United States

Site Status

Pacific Research Partners, LLC

Oakland, California, United States

Site Status

National Research Institute

Panorama City, California, United States

Site Status

Sierra Clinical Research

Roseville, California, United States

Site Status

Artemis Institute for Clinical Research

San Diego, California, United States

Site Status

Care Access Research

Santa Clarita, California, United States

Site Status

Encompass Clinical Research

Spring Valley, California, United States

Site Status

University Clinical Investigators, Inc.

Tustin, California, United States

Site Status

Diablo Clinical Research

Walnut Creek, California, United States

Site Status

Chase Medical Research, LLC

Waterbury, Connecticut, United States

Site Status

ALL Medical Research, LLC

Cooper City, Florida, United States

Site Status

Clinical Research of South Florida

Coral Gables, Florida, United States

Site Status

Suncoast Research Group, LLC

Miami, Florida, United States

Site Status

New Horizon Research Center

Miami, Florida, United States

Site Status

Oviedo Medical Research

Oviedo, Florida, United States

Site Status

Urban Family Practice Associates, PC

Marietta, Georgia, United States

Site Status

In-Quest Medical Research, LLC- Peachtree Corners

Peachtree Corners, Georgia, United States

Site Status

Pacific Diabetes & Endocrine Center

Honolulu, Hawaii, United States

Site Status

East West Medical Institute

Honolulu, Hawaii, United States

Site Status

Elite Clinical Trials LLLP

Blackfoot, Idaho, United States

Site Status

Saltzer Medical Group. P.A.

Nampa, Idaho, United States

Site Status

Prairie Education and Research Cooperative

Springfield, Illinois, United States

Site Status

Synexus/Clinical Research Advantage

Evansville, Indiana, United States

Site Status

Midwest Institute for Clinical Research

Indianapolis, Indiana, United States

Site Status

Iderc, P.L.C.

West Des Moines, Iowa, United States

Site Status

InterMed, PA

Portland, Maine, United States

Site Status

MedStar Health Research Institute

Hyattsville, Maryland, United States

Site Status

NECCR PrimaCare Research, LLC

Fall River, Massachusetts, United States

Site Status

Aa Mrc Llc

Flint, Michigan, United States

Site Status

Troy Internal Medicine, PC

Troy, Michigan, United States

Site Status

Clinical Research Professionals

Chesterfield, Missouri, United States

Site Status

StudyMetrix Research, LLC

City of Saint Peters, Missouri, United States

Site Status

Montana Health Research

Billings, Montana, United States

Site Status

Glacier View Research Institute

Kalispell, Montana, United States

Site Status

Premier Research

Trenton, New Jersey, United States

Site Status

Manhattan Medical Research

New York, New York, United States

Site Status

Great Lakes Medical Research

Westfield, New York, United States

Site Status

Metrolina Internal Medicine, P.A.

Charlotte, North Carolina, United States

Site Status

Diabetes & Endocrinology Consultants PC

Morehead City, North Carolina, United States

Site Status

Aventiv Research

Columbus, Ohio, United States

Site Status

Intend Research

Norman, Oklahoma, United States

Site Status

IPS Research Company

Oklahoma City, Oklahoma, United States

Site Status

The Corvallis Clinic P.C.

Corvallis, Oregon, United States

Site Status

Summit Research Network Inc

Portland, Oregon, United States

Site Status

Heritage Valley Medical Group, Inc.

Beaver, Pennsylvania, United States

Site Status

Detweiler Family Medicine

Lansdale, Pennsylvania, United States

Site Status

Preferred Primary Care Physicians

Pittsburgh, Pennsylvania, United States

Site Status

Sudir Bansal M.D. Inc.

Warwick, Rhode Island, United States

Site Status

PMG Research of Charleston, LLC

Moncks Corner, South Carolina, United States

Site Status

Chattanooga Research and Medicine (CHARM)

Chattanooga, Tennessee, United States

Site Status

Dallas Diabetes Endocrine Center

Dallas, Texas, United States

Site Status

Southern Endocrinology and Associates PA

Mesquite, Texas, United States

Site Status

Consano Clinical Research

Shavano Park, Texas, United States

Site Status

Martin Diagnostic Clinic

Tomball, Texas, United States

Site Status

ClinPoint Trials, LLC

Waxahachie, Texas, United States

Site Status

Progressive Clinical Research

Bountiful, Utah, United States

Site Status

Advanced Research Institute

Ogden, Utah, United States

Site Status

Manassas Clinical Research Center

Manassas, Virginia, United States

Site Status

Clinical Research Partners, LLC

Richmond, Virginia, United States

Site Status

Capital Clincial Research Center

Olympia, Washington, United States

Site Status

Walla Walla Clinic

Walla Walla, Washington, United States

Site Status

Wenatchee Valley Hospital & Clinics

Wenatchee, Washington, United States

Site Status

Prevea Clinic, Inc

Green Bay, Wisconsin, United States

Site Status

Centro Medico CICEMO

Caba, Buenos Aires, Argentina

Site Status

CEDIC-Centro de Investigaciones Clinicas

Caba, Buenos Aires, Argentina

Site Status

Investigaciones Medicas IMOBA S.R.L.

Caba, Buenos Aires, Argentina

Site Status

Centro de Investigaciones Metabólicas (CINME)

Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

Site Status

Centro Medico Dr Laura Maffei Investigacion Clinica Aplicada

Ciudad Autonoma de Buenos Aire, Buenos Aires, Argentina

Site Status

Centro de Investigacion y Prevencion Cardiovascular (CIPREC)

Ciudad Autonoma de, Buenos Aires, Argentina

Site Status

Instituto de Investigaciones Clinicas Mar del Plata

Mar del Plata, Buenos Aires, Argentina

Site Status

CIPADI

Godoy Cruz, Mendoza Province, Argentina

Site Status

AXISMED SRL - Bioclinica Research Network

Buenos Aires, , Argentina

Site Status

CENUDIAB

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

Centro Médico Viamonte

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

Instituto Centenario

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

Cemediab - Centro Médico Diabetológico Dr. Alejandro Chertkoff

Ciudad Autonoma de Buenos Aire, , Argentina

Site Status

Mautalen Salud e Investigación - Servicio de Endocrinología

Ciudad Autonoma de Buenos Air, , Argentina

Site Status

Instituto Medico Strusberg

Córdoba, , Argentina

Site Status

Centro Medico Privado San Vicente Diabetes

Córdoba, , Argentina

Site Status

Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC

Córdoba, , Argentina

Site Status

Landesklinikum Korneuburg-Stockerau, Standort Stockerau

Stockerau, Lower Austria, Austria

Site Status

Universitätsklinikum Graz

Graz, Styria, Austria

Site Status

Ordination Dr. Evelyn Fließer-Görzer

Saint Stefan Ob Stainz, Styria, Austria

Site Status

VIVIT Institut am LKH Feldkirch

Feldkirch, Vorarlberg, Austria

Site Status

KA Rudolfstiftung

Vienna, , Austria

Site Status

Zentrum für klinische Studien Dr. Ursula Hanusch GmbH

Vienna, , Austria

Site Status

Bailey Clinic

Red Deer, Alberta, Canada

Site Status

Aggarwal and Associates Ltd

Brampton, Ontario, Canada

Site Status

T. Nemtean Medicine Professional Corporation

Mississauga, Ontario, Canada

Site Status

Bluewater Clinical Research Group Inc

Sarnia, Ontario, Canada

Site Status

Stayner Medical Clinic

Stayner, Ontario, Canada

Site Status

Dr. Anil K. Gupta Medicine Professional Corporation

Toronto, Ontario, Canada

Site Status

Iatriko Palaiou Falirou, Medical Center

Palaió Fáliro, Athens, Greece

Site Status

Laiko General Hospital of Athens

Ampelokipoi, Attica, Greece

Site Status

Gen Hospital of Athens G Gennimatas

Athens, Attica, Greece

Site Status

G.Papanikolaou General Hospital

Eksochi, Thessaloniki, Greece

Site Status

Thermi Clinic

Thermi, Thessaloniki, Greece

Site Status

Athens Euroclinic

Athens, , Greece

Site Status

University General Hospital of Larissa

Larissa, , Greece

Site Status

AHEPA Hospital

Thessaloniki, , Greece

Site Status

Ippokrateio General Hospital of Thessaloniki

Thessaloniki, , Greece

Site Status

Euromedica - General Clinic of Thessaloniki

Thessaloniki, , Greece

Site Status

Studium Egeszseghaz Kft.

Kalocsa, Bács-Kiskun county, Hungary

Site Status

Kenezy Gyula Korhaz es Rendelointezet

Debrecen, Hajdú-Bihar, Hungary

Site Status

Grof Esterhazy Korhaz es Rendelointezeti Szakrendelo

Pápa, Veszprém megye, Hungary

Site Status

Szent Margit Rendelointezet

Budapest, , Hungary

Site Status

ClinDiab Kft.

Budapest, , Hungary

Site Status

Strazsahegy Medicina Bt.

Budapest, , Hungary

Site Status

TRANTOR 99 Bt.

Budapest, , Hungary

Site Status

Kanizsai Dorottya Korhaz

Nagykanizsa, , Hungary

Site Status

Zala Megyei Szent Rafael Korhaz

Zalaegerszeg, , Hungary

Site Status

Maccabi Diabetes Clinic, Grand Canyon, North District, Haifa

Haifa, , Israel

Site Status

Linn Medical Center

Haifa, , Israel

Site Status

Hadassah Medical Center

Jerusalem, , Israel

Site Status

Meir Medical Center

Kfar Saba, , Israel

Site Status

Clalit Health Services - Shuali Clinic

Raanana, , Israel

Site Status

ZIV Medical Center

Safed, , Israel

Site Status

Sakhnin Community Clinic, Clalit Health Services

Sakhnin, , Israel

Site Status

Diabetes Medical Center (DMC)

Tel Aviv, , Israel

Site Status

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status

Azienda Ospedaliera Universitaria Careggi

Florence, Florence, Italy

Site Status

Istituto Clinico Humanitas

Rozzano, Milano, Italy

Site Status

A.O.U. Senese Policlinico Santa Maria alle Scotte

Siena, SI, Italy

Site Status

Azienda Ospedaliera Papa Giovanni XXIII

Bergamo, , Italy

Site Status

Policlinico Mater Domini

Catanzaro, , Italy

Site Status

Fondazione Universitaria degli Studi G D'Annunzio

Chieti, , Italy

Site Status

Ospedale Santa Maria Goretti

Latina, , Italy

Site Status

Policlinico Giaccone

Palermo, , Italy

Site Status

Ospedale Civile Maggiore Borgo Trento

Verona, , Italy

Site Status

Hospital Univ. Dr. Jose Eleuterio Gonzalez

Monterrey, Nuevo León, Mexico

Site Status

Investigacion en Salud y Metabolismo S.C

Chihuahua City, , Mexico

Site Status

NZOZ ZDROWIE Osteo-Medic

Bialystok, , Poland

Site Status

Poradnia Diabetologiczna SN ZOZ Lege Artis

Bialystok, , Poland

Site Status

NS ZOZ Osrodek Diabetologiczny " Popula"

Bialystok, , Poland

Site Status

Centrum Badan Klinicznych, PI House

Gdansk, , Poland

Site Status

NZOZ Salvia s.c.

Katowice, , Poland

Site Status

NZOZ Diab-Endo-Met

Krakow, , Poland

Site Status

Centrum Terapii Wspolczesnej J.M. Jasnorzewska S.K.A.

Lodz, , Poland

Site Status

Gabinety Terpa

Lublin, , Poland

Site Status

NZOZ Przychodnia Specjalistyczna MEDICA

Lublin, , Poland

Site Status

Centrum Medyczne OMEDICA

Poznan, , Poland

Site Status

Praktyka Lekarska

Poznan, , Poland

Site Status

Nzoz Neuro - Kard

Poznan, , Poland

Site Status

NZOZ Przychodnia Specjalistyczna Henryk RudzkiAndrzej Wittek

Ruda Śląska, , Poland

Site Status

Centralny Szpital Kliniczny MSW

Warsaw, , Poland

Site Status

Regionalna Poradnia Diabetologiczna

Wroclaw, , Poland

Site Status

Research and Cardiovascular Corp.

Ponce, PR, Puerto Rico

Site Status

Office: Dr. Luis Rivera Colon

San Juan, PR, Puerto Rico

Site Status

Clinical Research Puerto Rico, Inc.

San Juan, , Puerto Rico

Site Status

GCM Medical Group PSC

San Juan, , Puerto Rico

Site Status

S. C. Grandmed S.R.L., Str.

Oradea, Bihor County, Romania

Site Status

SC Gama Diamed SRL

Mangalia, Constanța County, Romania

Site Status

Spitalul Judetean de Urgenta Satu Mare

Satu Mare, Jud Satu-Mare, Romania

Site Status

CMI DNBM Dr. Pop Lavinia

Baia Mare, Maramureş, Romania

Site Status

Cosamext SRL

Târgu Mureş, Mureș County, Romania

Site Status

SC Diabmed Dr Popescu Alexandrina SRL

Ploieşti, Prahova, Romania

Site Status

SC Dianutrilife Medica SRL

Ploieşti, Prahova, Romania

Site Status

Centrul Medical Dr. Negrisanu

Timișoara, Timiș County, Romania

Site Status

Centrul Medical de Diagnostic si Tratament Ambulatoriu Neomed SRL

Brasov, , Romania

Site Status

Cabinetul Medical Nicodiab SRL

Bucharest, , Romania

Site Status

Easydiet SRL

Bucharest, , Romania

Site Status

SC Nutrilife SRL

Bucharest, , Romania

Site Status

SC Medcon SRL

Buzău, , Romania

Site Status

Centrul Medical Unirea SRL

Cluj-Napoca, , Romania

Site Status

Cabinet Medical Urodiamed S.R.L.

Craiova, , Romania

Site Status

Milena Sante SRL

Galati, , Romania

Site Status

SC Olimpia Med SRL

Iași, , Romania

Site Status

Regional Clinical Hospital

Saratov, Russian Federation, Russia

Site Status

Arkhangelsk Regional Clinical Hospital

Arkhangelsk, , Russia

Site Status

Arkhangelsk the first city clinical hospital

Arkhangelsk, , Russia

Site Status

Rostov State Medical University

Rostov-on-Don, , Russia

Site Status

City Hospital of Saint Martyr Elizabeth

Saint Petersburg, , Russia

Site Status

SPb GUZ "Diagnostic Center #85"

Saint Petersburg, , Russia

Site Status

Human care s.r.o.

Košice, Slovak Republic, Slovakia

Site Status

MediVet s.r.o.

Malacky, Slovak Republic, Slovakia

Site Status

Areteus s.r.o.

Trebišov, Slovak Republic, Slovakia

Site Status

Diacrin s.r.o.

Bratislava, , Slovakia

Site Status

Noemis, s.r.o.

Nové Mesto nad Váhom, , Slovakia

Site Status

FUNKYSTUFF s.r.o.

Nové Zámky, , Slovakia

Site Status

MUDr. Jan Culak, s.r.o.

Prievidza, , Slovakia

Site Status

DIA-MED CENTRUM s.r.o.

Púchov, , Slovakia

Site Status

Tatratrial s.r.o.

Rožňava, , Slovakia

Site Status

Hospital Infanta Luisa

Seville, Andalusia, Spain

Site Status

Clinica Juaneda

Palma de Mallorca, Balearic Islands, Spain

Site Status

Corporació Sanitaria Parc Tauli

Sabadell, Barcelona, Spain

Site Status

Hospital Universitario Marques De Valdecilla

Santander, Cantabria, Spain

Site Status

Hospital Universitario Quiron Madrid

Pozuelo de Alarcón, Madrid, Spain

Site Status

Instituto de Ciencias medicas

Alicante, , Spain

Site Status

Clinica San Pedro

Almería, , Spain

Site Status

Centre Medico Teknon

Barcelona, , Spain

Site Status

Hospital Clinico Universitario San Cecilio

Granada, , Spain

Site Status

Virgen de Las Nieves

Granada, , Spain

Site Status

Centro Especialidades San Jose Obrero (Barbarela)

Málaga, , Spain

Site Status

Clinica Nuevas Tecnologias en Diabetes y Endocrinologia

Seville, , Spain

Site Status

Hospital Universitario Virgen Macarena

Seville, , Spain

Site Status

Policlinica Galileo

Teruel, , Spain

Site Status

Chung Shan Medical University Hospital

Taichung, , Taiwan

Site Status

Taichung Veterans General Hospital

Taichung, , Taiwan

Site Status

Chi-Mei Medical Center

Tainan City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Austria Canada Greece Hungary Israel Italy Mexico Poland Puerto Rico Romania Russia Slovakia Spain Taiwan

References

Explore related publications, articles, or registry entries linked to this study.

Ferdinand KC, Dunn J, Nicolay C, Sam F, Blue EK, Wang H. Weight-dependent and weight-independent effects of dulaglutide on blood pressure in patients with type 2 diabetes. Cardiovasc Diabetol. 2023 Mar 9;22(1):49. doi: 10.1186/s12933-023-01775-x.

Reference Type DERIVED
PMID: 36894938 (View on PubMed)

Cox DA, Wang H, Nicolay C, Bethel MA. Effect of expanded dulaglutide weekly doses (3.0 mg and 4.5 mg) on cardiovascular disease risk factors in participants with type 2 diabetes at increased cardiovascular disease risk: a post hoc analysis of the AWARD-11 study. Diabetes Obes Metab. 2022 Sep;24(9):1770-1778. doi: 10.1111/dom.14762. Epub 2022 May 29.

Reference Type DERIVED
PMID: 35546790 (View on PubMed)

Frias JP, Bonora E, Nevarez Ruiz L, Li YG, Yu Z, Milicevic Z, Malik R, Bethel MA, Cox DA. Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11). Diabetes Care. 2021 Mar;44(3):765-773. doi: 10.2337/dc20-1473. Epub 2021 Jan 4.

Reference Type DERIVED
PMID: 33397768 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

https://www.lillytrialguide.com/en-US/studies/adult-type-2-diabetes/GBGL#?postal=

A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes (AWARD-11)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H9X-MC-GBGL

Identifier Type: OTHER

Identifier Source: secondary_id

2017-003490-33

Identifier Type: EUDRACT_NUMBER

Identifier Source: secondary_id

16877

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Phase 3 Study of HS-20094 in Patients With T2DM
NCT07156539 NOT_YET_RECRUITING PHASE3